Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sofituzumab (MMUC 1206A) is a humanized monoclonal antibody targeting the MUC16 antigen, specifically the recombinant V-kappa immunoglobulin variant [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Sofituzumab (MMUC 1206A) is a humanized monoclonal antibody targeting the MUC16 antigen, specifically the recombinant V-kappa immunoglobulin variant [1]. |
Synonyms | MMUC 1206A |
Molecular Weight | N/A |
CAS No. | 1615692-28-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sofituzumab 1615692-28-8 MMUC 1206A inhibitor inhibit